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Atrial ﬁbrillation (AF) ablation is a procedure that is
performed routinely in advanced countries. Equipment such
as 3D anatomic mapping systems, cryoablation, contact
force sensing catheters, and general anesthesia with exten-
sive monitoring are increasingly used to effectively perform
these procedures. The cost of the disposable equipment alone
for an AF ablation can exceed $10,000.1 In countries in the
developing world, with limited economic resources, these
technologies may not be available. Similar to developed
countries, the developing world is facing a global epidemic
of AF. Unfortunately, in these countries this arrhythmia,
particularly in women, is associated with high rates of
mortality.2 This mortality is often driven, in part, by the
long-term access to therapies that may impact outcomes. An
AF ablation, if successful, can impact arrhythmia-free
survival and lower AF-related comorbidities.3 Unlike anti-
arrhythmic medications for AF, an ablation offers potential
as a singular therapy. As such, ablation procedures may have
a unique impact on the natural history of AF in developing
countries. However, undertaking an AF ablation with no
prior institutional or country experience can pose unique
challenges. This case study describes the ﬁrst AF ablation
procedure performed in Cambodia along with challenges of
performing the case in a country with limited economic
resources.Case report
The patient is a 55-year-old Cambodian woman who had
drug-refractory, symptomatic, nonvalvular AF. The patient
had a history of hypertension as her primary risk factor forKEYWORDS Ablation; Atrial ﬁbrillation; Cambodia; Developing world
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3.8 vcm2 and a left ventricular systolic ejection fraction of
60% without left ventricular hypertrophy. The patient was
placed on dabigitran for 1 month prior to the ablation
procedure and this was discontinued 48 hours prior to the
ablation. Dabigitran, rather than warfarin, was chosen
because it is the only novel oral anticoagulant that is
available in Cambodia. Warfarin is generally available in
Cambodia, but the lack of routine access to prothrombin time
measurements can make dosing and monitoring of the drug
challenging. As such, when possible dabigitran is a preferred
agent. The patient’s antiarrhythmic, sotalol, was also dis-
continued 48 h prior to the scheduled procedure.
The case was performed at Calmette Hospital in Phnom
Penh, Cambodia. The hospital has 1 cardiac catheterization
laboratory that is used for both interventional cardiology
and electrophysiology. The room is equipped with a mono-
plane Toshiba ﬂuoroscopy system. There is also a GE
Pruka Cardiolab recording system with 32 channels and a
Bloom stimulator. Ablation energy was delivered via an IBI
generator.
The patient underwent induction of deep conscious sedation.
The right and left femoral veins were cannulated using a
modiﬁed Seldinger technique. Two 8 French sheaths were
inserted in the right femoral vein and 1 7 French sheath was
inserted in the left femoral vein. Through the left femoral vein a
duodecapolar catheter (Livewire; St Jude Medical, St Paul, MN)
was advanced into the coronary sinus. The patient was given a
bolus of 8000 units (U) of heparin and received an additional
1000 U hourly. A transesophageal echocardiogram (TEE) probe
was easily advanced into the esophagus to assist with transseptal
catheterization. Using ﬂuoroscopy and TEE imaging, a Brock-
enbrough needle 1 was advanced into the left atrium. We
conﬁrmed the location by TEE imaging and the presence of the
mean pressure recordings. An SL 1 sheath (St JudeMedical) was
then advanced into the left atrium. This procedure was repeated
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KEY TEACHING POINTS
 Atrial ﬁbrillation ablation can be performed in
developing countries without the aid of expensive
disposable equipment and a 3D anatomic mapping
system.
 Atrial ﬁbrillation ablation is an alternative therapy
to patients in the developing world and can be
offered as a safe and effective treatment option.
 Operators with experience in atrial ﬁbrillation
ablation are needed to train physicians in the
developing world to perform the procedure.
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(Saﬁre Blue; St Jude Medical) was advanced into the left
atrium. Through the other a multipolar circular electrode
catheter (Inquiry Optima; St Jude Medical) was inserted into
the left atrium. The catheter was advanced deep into the
pulmonary veins and the sheath was then advanced over the
catheter to the pulmonary vein oriﬁce. Contrast venography
was performed in all 4 of the veins. The location and general
anatomies of all veins were then drawn directly onto the
ﬂuoroscopy monitor for reference using a dry-erase marker
(Figure 1).
The baseline rhythm was AF with a coronary cycle
length of 150200 ms. The circular mapping catheter was
positioned near the pulmonary vein ostium as delineated by
venography characteristics. The ablation strategy was ipsi-
lateral vein isolation with a wide area of circumferential
ablation lesion sets. Ablative injury was delivered at 30 W
in a continuous manner along the anterior walls and reduced
to 20 W for 20 s intervals along the posterior walls to
perform pulmonary vein isolation. After entrance block was
achieved the subsequent veins were targeted. After iso-
lation of the left-sided pulmonary veins and during isolation
of the right superior pulmonary vein, the patient converted
to sinus rhythm. Ablation was continued until all veins were
isolated. AF was not inducible at study completion. TheFigure 1 The operator showing the ostium of the left upper pulmonary
vein with the borders that were drawn with dry-erase marker.total procedure time was approximately 6 h and the total
ﬂouroscopy time was approximately 1 h.Discussion
Several challenges were noted during the case, in compar-
ison to an AF ablation performed in the developed world. In
contrast to the equipment available in most developed
nations, there is limited anesthesia technology, ultrasound
imaging, and pharmacology available in Cambodia. In
addition, a 3D anatomic mapping system is not available in
Cambodia.
General anesthesia is frequently chosen in the developed
world for sedation for AF ablations. In Calmette Hospital,
the only anesthesia machine was being used concurrently in
another case. Therefore, conscious sedation with a laryngeal
mask airway and manual resuscitatorassisted ventilation
was chosen. The patient received total intravenous general
anesthesia with a combination of versed, fentanyl, and
propafol. The patient remained hemodynamically stable
throughout the case, with the exception of mild hypotension.
As the only pressor available was phenylephrine, this was
chosen and titrated to achieve a mean systolic blood pressure
of 60 mm Hg.
Another unique challenge in Cambodia is the limited
ultrasound equipment and experience to guide catheter-based
procedures. In the developed world, an intracardiac ultra-
sound catheter is frequently advanced into the right atrium to
visualize the intraatrial septum and locate the site of trans-
septal puncture. Rather, a TEE probe was borrowed from the
cardiothoracic operating room and used to guide the trans-
septal puncture. The probe was then removed and returned to
the operating room where it was directly needed for another
case. Additional monitoring, including in the setting of mild
hypotension, was performed using ﬂuoroscopic imaging.
Anticoagulation is essential to minimize thromboembolic
complications during AF ablation. Frequent monitoring of
activation clotting times is critical in the safe use of heparin
anticoagulation. Multiple factors can inﬂuence heparin
kinetics during ablation and, as such, empiric dosing is
limited. In this case, heparin was infused but there was no
method to assess the activation clotting time. Therefore, the
patient was given a bolus with a weight-based estimate of
8000 U of heparin prior to the transseptal puncture and then
infused 1000 U every hour. To minimize the impact of tool-
adherent thrombus, the sheaths were pulled back into the
right atrium.
A 3D anatomic mapping system is frequently used in the
developed world to locate the pulmonary veins, understand
the left atrial anatomy, guide ablation, and minimize
radiation exposure. Since there are no 3D mapping systems
available in Cambodia, a pulmonary venogram at a ﬁxed left
anterior oblique angulation was performed with both long
sheaths in ipsilateral veins. The venogram was performed
and then the outline of the veins was traced directly on the
screen. This gave a general guide to the operators of the
pulmonary vein location. The circular mapping catheter was
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general map of the anatomic location. The challenge with
these alternative guidance approaches was that we became
more reliant on ﬂuoroscopy. The total exposure was more
than 5 times that reported in most experienced centers in the
United States.
Unfortunately, we did not have access to an esophageal
temperature probe. In addition, the anesthesia status impeded
the use of an esophageal probe. In this regard, the lighter
anesthesia was helpful, as pain perception was used to
determine if esophageal injury was developing. Fortunately,
the patient did not report any pain. However, subjective
reporting of esophageal pain has signiﬁcant limitations in
accuracy and reliability. Conscious sedation rather than
general anesthesia has been shown to reduce risk of
esophageal injury.4 As such, ablation lesions on the posterior
wall were limited to 20 W for 20 s each.
The challenges present in Cambodia were, in part, over-
come by the experience of the operators. Combined, 2 of the
operators have performed over 1000 AF ablations. When
initially developed, AF ablation was performed with ﬂuoro-
scopy only, without 3D anatomic mapping.5 Fluoroscopy-
guided ablation procedures, however, can expose both
patients and medical staff to potentially deleterious doses
of radiation. In addition, the position of multiple catheters,
including the ablation catheter, can be determined and
previous areas of ablation can be marked with 3D anatomic
mapping. Owing to the overwhelming advantages of 3D
anatomic mapping, ablation with ﬂuoroscopy is no longer
routinely performed in the developed world. In fact, in some
centers the procedure is performed without the aid of
ﬂuoroscopy.6 Given the limited technology, the experience
of the ﬁrst 2 operators was essential in completing the case.
In order to perform these cases in the developing world,
operators with experience will be essential to the training of
physicians in the developed world. Once trained, operators in
the developing world can perform this procedure without the
aid of 3D anatomic mapping.
Postoperatively, the patient remained hemodynamically
stable and was arrhythmia free. As is the custom in thecountry, the patient remained as an inpatient as long as she
had any chest discomfort symptoms. For the ﬁrst few days
she reported symptoms of pericardial pain. On day 3
postablation, the patient became chest pain free and was
eventually discharged. Upon presentation for her 3-month
follow-up, she remained AF free and off antiarrhythmic drug
therapy. Since her CHADS2 score was 1, her dabigatran was
discontinued.Conclusion
In summary, this case illustrates that there are limitations in
resources that are present in the developing world, but that a
complex ablation such as AF ablation can be performed
safely and successfully. Despite the lack of an anesthesia
machine and ultrasound imaging equipment and a 3D
anatomic mapping system, the procedure could still be
performed. We hope that this case serves as a guide to help
electrophysiologists in developing countries that are consid-
ering AF ablation.References
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